Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Nilius

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Current Medical Research and Opinion|January 30, 2007
Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adultsPhilip A Giordano, Dirk Elston, Bolanle K Akinlade, et al.
Antimicrobial Agents and Chemotherapy|November 4, 2015
No Need for Lopinavir Dose Adjustment during Pregnancy: a Population Pharmacokinetic and Exposure-Response Analysis in Pregnant and Nonpregnant HIV-Infected SubjectsAhmed Hamed Salem, Aksana Kaefer Jones, Marilia Santini-Oliveira, et al.
HIV Clinical Trials|December 20, 2011
Examination of noninferiority, safety, and tolerability of lopinavir/ritonavir and raltegravir compared with lopinavir/ritonavir and tenofovir/ emtricitabine in antiretroviral-naïve subjects: the progress study, 48-week resultsJacques Reynes, Adebayo Lawal, Federico Pulido, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
Dynamics of clarithromycin and azithromycin efficacies against experimental Haemophilus influenzae pulmonary infectionJ D Alder, P J Ewing, A M Nilius, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
In vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinoloneAngela M Nilius, Linus L Shen, Dena Hensey-Rudloff, et al.
The Journal of Antibiotics|May 1, 1996
3-Keto-11,12-carbazate derivatives of 6-O-methylerythromycin A synthesis and in vitro activityG Griesgraber, Y S Or, D T Chu, et al.
Diagnostic Microbiology and Infectious Disease|July 11, 2002
Antimicrobial susceptibility and molecular characterization of community-acquired methicillin-resistant Staphylococcus aureusLaurel S Almer, Virginia D Shortridge, Angela M Nilius, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2005
Synthesis and antibacterial activity of 5-methoxy- and 5-hydroxy-6-fluoro-1,8-naphthyridone-3-carboxylic acid derivativesT Matthew Hansen, Yu-Gui Gu, Tamara M Rehm, et al.
Current Medical Research and Opinion|September 14, 2006
Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young childrenStan L Block, Jordana K Schmier, Gerard F Notario, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Design, synthesis and structure-activity relationships of 6-O-arylpropargyl diazalides with potent activity against multidrug-resistant Streptococcus pneumoniaeHong Yong, Yu Gui Gu, Richard F Clark, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Current Medical Research and Opinion|January 30, 2007
Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adultsPhilip A Giordano, Dirk Elston, Bolanle K Akinlade, et al.
Antimicrobial Agents and Chemotherapy|November 4, 2015
No Need for Lopinavir Dose Adjustment during Pregnancy: a Population Pharmacokinetic and Exposure-Response Analysis in Pregnant and Nonpregnant HIV-Infected SubjectsAhmed Hamed Salem, Aksana Kaefer Jones, Marilia Santini-Oliveira, et al.
HIV Clinical Trials|December 20, 2011
Examination of noninferiority, safety, and tolerability of lopinavir/ritonavir and raltegravir compared with lopinavir/ritonavir and tenofovir/ emtricitabine in antiretroviral-naïve subjects: the progress study, 48-week resultsJacques Reynes, Adebayo Lawal, Federico Pulido, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
Dynamics of clarithromycin and azithromycin efficacies against experimental Haemophilus influenzae pulmonary infectionJ D Alder, P J Ewing, A M Nilius, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
In vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinoloneAngela M Nilius, Linus L Shen, Dena Hensey-Rudloff, et al.
The Journal of Antibiotics|May 1, 1996
3-Keto-11,12-carbazate derivatives of 6-O-methylerythromycin A synthesis and in vitro activityG Griesgraber, Y S Or, D T Chu, et al.
Diagnostic Microbiology and Infectious Disease|July 11, 2002
Antimicrobial susceptibility and molecular characterization of community-acquired methicillin-resistant Staphylococcus aureusLaurel S Almer, Virginia D Shortridge, Angela M Nilius, et al.
Bioorganic & Medicinal Chemistry Letters|May 25, 2005
Synthesis and antibacterial activity of 5-methoxy- and 5-hydroxy-6-fluoro-1,8-naphthyridone-3-carboxylic acid derivativesT Matthew Hansen, Yu-Gui Gu, Tamara M Rehm, et al.
Current Medical Research and Opinion|September 14, 2006
Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young childrenStan L Block, Jordana K Schmier, Gerard F Notario, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Design, synthesis and structure-activity relationships of 6-O-arylpropargyl diazalides with potent activity against multidrug-resistant Streptococcus pneumoniaeHong Yong, Yu Gui Gu, Richard F Clark, et al.
Pageof 7